List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 580 studies with search of: "Oxaliplatin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
Condition: Gastric Cancer
Interventions: Drug: Irinotecan;   Drug: Oxaliplatin;   Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin
2 Recruiting Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
Conditions: Hepatoma;   Advanced Solid Tumor
Interventions: Drug: irinotecan and ON 01910.Na;   Drug: oxaliplatin and ON 01910.Na
3 Recruiting Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
Condition: Advanced Solid Tumors
Interventions: Drug: ON 01910.Na and irinotecan;   Drug: ON 01910.Na and oxaliplatin
4 Recruiting Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
Condition: Metastatic Gastric or GEJ Cancer
Interventions: Drug: Docetaxel + oxaliplatin;   Drug: Docetaxel + oxaliplatin + cetuximab
5 Recruiting Docetaxel and Oxaliplatin in Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Drug: docetaxel + oxaliplatin;   Drug: docetaxel + oxaliplatin + 5-FU;   Drug: docetaxel + oxaliplatin + capecitabine
6 Recruiting Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Condition: Colorectal Neoplasm
Interventions: Drug: oxaliplatin;   Drug: S-1;   Drug: Capecitabine
7 Recruiting Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Oxaliplatin+ 5FU/ Radiation/FOLFOX 6
8 Active, not recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Drug: Floxuridine, Oxaliplatin, CPT-11;   Drug: Floxuridine, Oxaliplatin, CPT-11
9 Recruiting Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: S-1 & Oxaliplatin;   Drug: Capecitabine & Oxaliplatin
10 Recruiting Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: intravenous docetaxel with intraperitoneal oxaliplatin;   Drug: intravenous oxaliplatin with intraperitoneal docetaxel
11 Recruiting Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Drug: docetaxel;   Drug: Oxaliplatin;   Drug: S-1
12 Recruiting Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Irinotecan;   Drug: Leukovorin;   Drug: Oxaliplatin;   Drug: 5-FLUOROURACIL;   Drug: Cetuximab
13 Not yet recruiting Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Advanced Solid Tumors;   Cancer;   Gastrointestinal Disease;   Rectal Disease
Interventions: Drug: capecitabine/oxaliplatin/bevacizumab/RAD001 (XELOX-A-Ev);   Drug: bevacizumab/capecitabine/oxaliplatin (XELOX-A)
14 Active, not recruiting Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cediranib;   Drug: FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin);   Drug: XELOX (Capecitabine and Oxaliplatin)
15 Active, not recruiting Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: 21Capecitabine + bevacizumab + oxaliplatin;   Drug: 1Capecitabine + oxaliplatin + bevacizumab + cetuximab
16 Recruiting Phase I Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
Conditions: Advanced Colorectal Cancer;   Metastatic Colorectal Cancer;   Responsive to Fluoropyrimidines
Interventions: Drug: lapatinib;   Drug: oxaliplatin;   Drug: capecitabine
17 Recruiting Trial Combination Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: irinotecan, oxaliplatin and cetuximab
18 Recruiting Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: docetaxel, oxaliplatin, capecitabine
19 Active, not recruiting Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma
Conditions: Cancer of the Gallbladder;   Cancer of the Biliary Tract
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin
20 Recruiting Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
Condition: Peritoneal Cancer
Interventions: Drug: Bevacizumab;   Drug: Oxaliplatin;   Drug: Paclitaxel

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services